Our objective was to determine whether the consumption of green tea, coffee, or black tea influences the incidence of dementia and mild cognitive impairment (MCI) in older people. We conducted a population-based prospective study with Japanese residents aged >60 years from Nakajima, Japan (the Nakajima Project). Participants received an evaluation of cognitive function and blood tests. The consumption of green tea, coffee, and black tea was also evaluated at baseline. Of 723 participants with normal cognitive function at a baseline survey (2007–2008), 490 completed the follow up survey in 2011–2013. The incidence of dementia during the follow-up period (mean ± SD: 4.9±0.9 years) was 5.3%, and that of MCI was 13.1%. The multiple-adjusted odds ratio for the incidence of overall cognitive decline (dementia or MCI) was 0.32 (95% CI: 0.16–0.64) among individuals who consumed green tea every day and 0.47 (95% CI: 0.25–0.86) among those who consumed green tea 1–6 days per week compared with individuals who did not consume green tea at all. The multiple-adjusted odds ratio for the incidence of dementia was 0.26 (95% CI: 0.06–1.06) among individuals who consumed green tea every day compared with those who did not consume green tea at all. No association was found between coffee or black tea consumption and the incidence of dementia or MCI. Our results indicate that green tea consumption is significantly associated with reduced risk of cognitive decline, even after adjustment for possible confounding factors.
Citation: Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, Iwasa K, et al. (2014) Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline. PLoS ONE 9(5): e96013. doi:10.1371/journal.pone.0096013
Editor: Antony Bayer, Cardiff University, United Kingdom
Received: February 20, 2014; Accepted: April 2, 2014; Published: May 14, 2014
Copyright: © 2014 Noguchi-Shinohara et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by a Grant for the Hokuriku Innovation Cluster for Health Science (to M.Y.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. In addition, this work was also supported from the Research on Dementia, Health and Labour Sciences Research Grants (to M.Y.) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Coffee and tea are widely consumed around the world. In Japan and other Asian countries, green tea is a popular beverage, whereas in the Western countries, black tea is popular. Coffee, tea and tea-related polyphenols have been extensively studied for their neuroprotective effects and their potential for preventing neurodegenerative diseases, including Alzheimer's disease (AD) –. Coffee and tea contain large amounts of caffeine, which has been investigated for its neuroprotective effects both in vivo and in vitro , . However, evidence from cohort studies that examine the relationship between green tea or coffee consumption and dementia is limited and inconsistent.
Several longitudinal studies – have investigated the relationship between coffee consumption and dementia, AD, or cognitive decline, but findings from these studies are also inconsistent. In addition, longitudinal studies of black tea consumption have not found any association with reduced risks for dementia, AD, or cognitive decline , . One cross-sectional study has shown that higher green tea consumption is associated with lower prevalence of cognitive impairment .
We hypothesized that the consumption of beverages rich in polyphenols and caffeine, such as green tea, coffee, or black tea, would be protective and would delay the onset of dementias including AD. In the present longitudinal study, we aimed to determine whether the consumption of the aforementioned beverages is associated with the incidence of dementia and mild cognitive impairment (MCI) in the general population.
The Nakajima Project was a population-based cohort study that investigated correlations between lifestyle and the prevalence of dementia in elderly Japanese individuals. The study was conducted in Nakajima, in the Nanao district of Ishikawa Prefecture, Japan. The study design was described previously , .
Participants were recruited as a part of the Nakajima Project. The baseline survey was conducted between 2007 and 2008. On April 1, 2007, 2,845 people who were 60 years or older were legally residing in Nakajima. These elderly residents were eligible to receive a free evaluation of their physical health, which included a battery of neurological and cognitive tests that examined cognitive function. Recruitment began in May 2007 by distributing flyers to Nakajima residents. Nakajima project was supported by Nanao city, and the information of the residence was used to list target candidates. The baseline survey included questionnaires regarding personal lifestyle, medical conditions, and neuropsychological tests. All participants lived in the community at the time of the baseline survey. Blood samples were also collected, and ascorbic acid (vitamin C) levels and ApoE phenotypes were determined for all participants. The study was conducted by 14 neurologists, two psychologists, seven nurses, one physiotherapist, and one occupational therapist, all of whom were specifically trained for this study.
Each participant completed a self-administered questionnaire that queried sociodemographic data (including age, sex, and education), past medical history (hypertension, hyperlipidemia, and diabetes mellitus), smoking habits, physical activities/hobbies, and green tea, coffee, and black tea consumption. The trained researchers reviewed the completed questionnaires to identify inconsistent or unanswered items. Green tea, coffee, and black tea consumption was quantified by the frequency of consumption of each beverage using the choice of 0, 1, 2, 3, 4, 5, or 6 times/week or every day. For the present analysis, we further divided this category into three groups: zero (no consumption), 1–6 days/week, and every day.
We assessed participants' cognitive status with the Mini-Mental State Examination (MMSE)  and the Clinical Dementia Rating (CDR) –. Higher MMSE scores indicate higher cognitive function, and the maximum score is 30 points. Standard cut point of <24 out of 30 indicates cognitive impairment . CDR is a dementia-staging device that rates cognitive function from none to maximal along five levels of impairment (rated as 0, 0.5, 1, 2, or 3) in each of the following six domains: memory, orientation, judgment and problem solving, function in community affairs, home and hobbies, and personal care. A global CDR score was calculated using an algorithm that takes into account each of these domain subscores. The possible scores for global CDR were 0 (indicating a normal healthy individual with no cognitive or functional deficits), 0.5 (a normal healthy individual with questionable cognitive and/or functional abilities), 1 (mild dementia), 2 (moderate dementia), and 3 (severe dementia).
High-performance liquid chromatography (HPLC) was used to measure total serum ascorbic acid concentrations . ApoE phenotype was determined using isoelectric electrophoresis as described by Kamboh et al .
Diagnosis of dementia was based on the guidelines of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R) . Diagnosis of MCI was established according to the International Working Group on general criteria for MCI . The MCI criteria state that (1) a person should be judged as abnormal using modalities other than those used to fulfill the DSM-III-R dementia criteria, (2) the person's functional activities are mainly preserved or at least impairment is minimal, and (3) the person should have evidence of cognitive decline, either by self-assessment and/or by an informant report in conjunction with deficits in objective cognitive tasks. Among participants without dementia, a CDR score of 0.5 was used as the objective cognitive impairment value to denote cognitive and functional impairment consistent with MCI.
During 2011 and 2013, all subjects who could be contacted and who agreed to participate in the follow-up survey were interviewed to determine whether their health status or cognitive functioning had changed. The follow-up survey was conducted in public halls or at the participants' homes. Participants completed the same questionnaires and underwent the same neurological tests that were administered at the initial baseline survey. In addition, we visited seven individuals who were institutionalized in long-term care facilities or hospitals, and administered the same examinations after obtaining written informed consent from their families. Participants who died or who left Nakajima before the follow-up was conducted were excluded from the analysis, and the date they died or moved away were obtained from Nanao city.
Standard protocol approvals and patient consents
This study was conducted with the approval of the medical ethics review board of Kanazawa University (Kanazawa, Japan). All participants provided written informed consent by signing a form that described the purpose and procedures of the study, the potential risks and benefits associated with participation, the strict voluntary nature of participation, the right to withdraw from the research without prejudice or penalty, and a guarantee of confidentiality and security of personal data.
Baseline characteristics were evaluated using a one-way ANOVA for continuous variables and the chi-square test for categorical variables. Trend tests were conducted for green tea, coffee, and black tea consumption to test the significance of these variables. Univariate and multivariate logistic regression models were used to analyze the independent effects of green tea, coffee, and black tea consumption on the risk of developing dementia or MCI so that the lowest category served as the reference group. Model 1 was sex- and age- adjusted. Model 2 was further adjusted for history of hypertension, diabetes mellitus, and hyperlipidemia, formal education, and ApoE phenotype status (ApoE E4+ or E4−). Model 3 was fully adjusted and included smoking status, alcohol consumption, green tea, coffee, and/or black tea consumption, physical activities and/or hobbies. A two-sided P-value less than 0.05 was considered statistically significant in all analyses. The SPSS software package (version 12.0J; SPSS Inc., Chicago, IL) was used to perform all statistical analyses.
Of the 2,845 potential candidates, 982 voluntarily participated in the brain-function examination conducted at public town halls in 2007–2008 (participation rate: 34.5%). We excluded 217 subjects from the analysis because of dementia (n = 8), MCI (n = 205), or failure to complete the cognitive tests (n = 4). We further excluded 42 subjects with a MMSE score of <24 at the initial baseline survey. Thus, 723 participants were judged to have normal cognitive function at the initial baseline survey. Of the 723 participants with normal cognitive function, 55 died, 5 moved, 167 did not repeat cognitive testing at follow-up, and 6 incompletely answered the beverage-frequency questionnaire at the initial baseline survey. Thus, data from 490 participants were included in the final analysis. The sociodemographic characteristics between participants included in the final analysis and subjects lost to follow-up did not differ in age, MMSE scores, or formal education years at the time of the baseline survey (Table S1).
With regard to green tea, 195 participants (39.8%) drank moderate amounts (1–6 days per week), 157 (32.0%) drank every day, and 138 (28.2%) did not drink green tea. With regard to coffee intake, 212 participants (43.3%) drank coffee every day, 180 (36.7%) drank moderate amounts (1–6 days per week), and 98 (20.0%) did not drink coffee. As for black tea consumption, 404 participants (82.4%) did not consume, whereas 86 (17.6%) consumed black tea at least 1 day per week. Because the number of participants drinking black tea for every day was too small (n = 6), we grouped together the participants drinking black tea for 1–6 days/week and every day.
Tables 1–3 show results from the baseline and follow-up surveys according to green tea, coffee, and black tea consumption categories. At baseline, participants who consumed larger amounts of green tea was younger (P<0.001), had more formal education (P<0.001), had higher MMSE scores (P<0.001), and had higher scores for current physical activities and/or hobbies (P = 0.008). More frequent consumption of coffee was associated with lower age (P<0.001) and higher ascorbic acid levels (P = 0.008) at baseline along with higher scores for current physical activities and/or hobbies (P = 0.02). Participants who did not consume black tea had fewer years of formal education (P = 0.005) and tended to have lower MMSE scores (P = 0.083) than those who consumed black tea more than 1 day per week.
During the follow-up survey (follow-up period, 4.9±0.9 years), we documented 26 participants with dementia and 64 participants with MCI. Participants who consumed larger amounts of green tea were younger (P = 0.001), and had higher MMSE scores (P = 0.001). More frequent consumption of coffee was associated with lower age (P<0.001) and higher MMSE scores (P = 0.016). As shown in Tables 1–3, more frequent consumption of green tea was associated with lower incidence of dementia and MCI (P = 0.009 and P = 0.001, respectively). In contrast, no association was found between the frequency of coffee or black tea consumption and the incidence of dementia or MCI.
The relationships between green tea consumption and the incidence of cognitive decline (dementia or MCI) are shown in Table 4. We found that green tea consumption was inversely associated with the incidence of dementia in both age- and sex-adjusted models. With regard to the incidence of dementia, multivariate odds ratios were 1.00 (reference) for not consuming green tea, 0.90 (95% CI: 0.34–2.35) (P = 0.826) for consuming green tea 1–6 days per week, and 0.26 (0.06–1.06) (P = 0.06) for consuming green tea every day. Regarding the incidence of cognitive decline (dementia or MCI), multivariate odds ratios were 1.00 (reference) for not consuming green tea, 0.47 (0.25–0.86) (P = 0.015) for consuming green tea 1–6 days per week, and 0.32 (0.16–0.64) (P = 0.001) for consuming green tea every day (Table 4).
This prospective longitudinal study demonstrated that daily green tea consumption is significantly associated with a decreased risk of cognitive decline (dementia or MCI), even after controlling for potential confounding factors. In addition, higher green tea consumption was inversely associated with dementia in both age- and sex- adjusted models. To the best of our knowledge, this is the first longitudinal study that examined the association between green tea and the incidence of dementia and cognitive decline. In a cross-sectional study, higher green tea consumption was associated with a lower prevalence of cognitive impairment . In that study, although cognitive function was assessed with MMSE, the incidence of dementia or MCI was not investigated.
In the present study, no relationship was found between coffee consumption and a risk of dementia or cognitive decline. In contrast, higher coffee consumption was reported to decrease the risk of AD over a 5-year period  and was associated with a decrease in cognitive decline in a 10-year follow-up . Furthermore, in the Three City Study , consuming more than three cups of a caffeinated beverage (coffee or black tea) per day was associated with a lower decline in cognitive tests among elderly women, but there was no relationship between caffeine consumption and dementia risk over a 4-year period, similar to our results. The relatively short follow-up period and the small sample size might be reasons why we did not observe protective effects of coffee against dementia or cognitive decline.
In the present study and in previous longitudinal studies , , no association was found between black tea consumption and the risk of dementia or cognitive decline. Drinking black tea was a relatively uncommon practice in the area of our study, which may have resulted in low statistical power.
Both green and black teas contain polyphenols, caffeine, L-theanine, and other nutrients. The major tea-related polyphenols present in green tea are catechins, especially epigallo catechin 3-gallate (EGCG), whereas black tea mainly contains theaflavins . In addition, green tea contains more myricetin compared with black tea . Other tea-related polyphenols such as quercetin, kaempferol, apigenin, and luteolin, are also present in both green and black tea, but the amounts of these polyphenols are not significantly different between tea types . EGCG is permeable to the blood brain barrier  and exerts neuroprotective and neurorescue effects against amyloid β (Aβ) toxicity by inhibiting Aβ aggregation  and production , . Myricetin inhibits Aβ aggregation, especially oligomerization in vitro , . Furthermore, oral administration of EGCG or myricetin prevents the development of AD pathology in AD-model mice , , . The positive relationships observed in this study between green tea consumption and both dementia and cognitive decline, and the null relationship between black tea consumption and either dementia or cognitive decline may support previously reported data –, – regarding significant neuroprotective effects of EGCG and myricetin.
The caffeine content is 40–57 mg/100 mL in coffee , 25.5 mg/100 mL in black tea, and only 15.3 mg/100 mL in green tea . Caffeine is a nonselective A1 and A2a adenosine receptor antagonist that stimulates cholinergic neurons . Chronic caffeine administration was shown to have neuroprotective effects in a mouse model of AD, indicating that decreased Aβ production is a likely mechanism . Moreover, both caffeine and adenosine A2a receptor antagonists prevent Aβ-induced cognitive deficits in mice . Our study suggests that the contribution of caffeine to cognitive function may be small due to the null relationship observed between coffee consumption and cognitive impairment.
High intake of ascorbic acid is associated with lower risk of AD . The content of ascorbic acid is 6 mg/100 mL in green tea, which is the most common source of ascorbic acid in Japan , . On the other hand, coffee and black tea do not contain ascorbic acid . We cannot exclude the possibility that ascorbic acid in green tea had a positive effect on cognitive function. However, this explanation was not supported by the findings that the serum levels of ascorbic acid were associated with the frequency of coffee consumption, but not green tea consumption, thereby indicating that the effects of ascorbic acid on cognitive function may be small. L-theanine, an amino acid rich in green and black teas, but not present in coffee, has antioxidative properties and neuroprotective effects through inhibition of both Aβ-induced oxidative stress and activation of the ERK1/p38 MAPK and NK-kB pathways . Further studies that determine L-theanine levels in participants are required.
We could not fully exclude the possibility that the analyses were confounded by unmeasured factors. For example, green tea consumption is associated a variety of health behavior or social factors, and previous studies have shown that physical activity and hobbies are associated with lower risk of dementia and MCI , . Hence, the association of more frequent consumption of green tea with more physical activities and hobbies reported here may not be surprising. However, we found that the inverse association between green tea consumption and incidence of dementia and cognitive decline was present even after adjustment for physical activities and hobbies. All participants were free from cognitive impairment and had at least MMSE score of 24 or higher at the time of the baseline survey. However, as lower MMSE scores were associated with smaller amounts of green tea consumption, participants who consumed smaller amounts of green tea might have had very mild cognitive impairment at baseline.
There are some limitations to the present study. First, because the sample size was relatively small, we did not assess the association of the combined frequency of green tea, coffee, and black tea consumption with incidence of dementia or cognitive decline. Second, because we did not include the question about the amounts of cups of beverage consumption at baseline survey, we could not assess the association between amounts of beverage consumption and cognitive decline. Third, we did not evaluate the causes of dementia and MCI with diagnostic tools such as neuroimaging and neuropathology. Further studies involving neuroimaging and neuropathology are required to reveal the cause of dementia and MCI in this population and to evaluate the effects of green tea consumption for each cause of dementia. Furthermore, among the number of subjects at baseline (n = 723), the valid response rate (67.8%, n = 490) was not high. The strengths of the current study are its longitudinal design and the opportunity to adjust for possible confounding factors.
In conclusion, higher green tea consumption was associated with lower incidence of cognitive decline (dementia or MCI) in an elderly Japanese population. Our results suggest that green tea consumption could be beneficial for reducing the risk of cognitive decline.
Characteristics of the participants including the final analysis and subjects lost to follow-up. Values expressed as mean (SD) unless otherwise indicated. MMSE: Mini-mental state examination.
We wish to thank all the residents of Nakajima for their participation in the present study. We thank Drs. Mitsuhiro Yoshita, Kazuya Takahashi, Tsuyoshi Hamaguchi, Ayumi Hamaguchi, Ichiro Nozaki, Yuko Motozaki, Akiyoshi Morinaga, Daisuke Noto, and Toyoteru Muroishi for their valuable help throughout this research. The authors would like to thank Enago (www.enago.jp) for the English language review.
Conceived and designed the experiments: MN-S SY CD KI KK HN M. Yamada. Performed the experiments: MN-S SY CD YI MS KI M. Yokogawa KA KK M. Yamada. Analyzed the data: MN-S. Contributed reagents/materials/analysis tools: MN-S SY. Wrote the paper: MN-S M. Yamada.
- 1. Levites Y, Weinreb O, Maor G, Youdim MBH, Mandel S (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 377: 1073–1082.
- 2. Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, et al. (2001) The green tea polyphenol (-)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70: 603–614.
- 3. Levites Y, Amit T, Mandel S, Youdim MBH (2003) Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidgenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 17: 952–954.
- 4. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, et al. (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 87: 172–181.
- 5. Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, et al. (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214: 177–187.
- 6. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, et al. (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25: 8807–8814.
- 7. Ho L, Varghese M, Wang J, Zhao W, Chen F, et al. (2012) Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutr Neurosci 15: 37–45.
- 8. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, et al. (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 142: 941–952.
- 9. Dall'Inga OP, Fett P, Gomes MW, Souza DO, Cunha RA, et al. (2007) Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice. Exp Neurol 203: 241–245.
- 10. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, et al. (2002) Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156: 445–453.
- 11. Gelder BM, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, et al. (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study. Eur J Clin Nutr 61: 226–232.
- 12. Ritchie K, Carriere I, Mendonca A, Portet F, Dartigues JF, et al. (2007) The neuroprotective effects of caffeine. A prospective population study (the Three City Study). Neurology 69: 536–545.
- 13. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study. J Alzheimers Dis 16: 85–91.
- 14. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia. The Honolulu-Asia Aging Study. Am J Epidemiol 159: 959–967.
- 15. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB (2006) Fruit and vegetable juices and Alzheimer's disease: The Kame project. Am J Med 119: 751–759.
- 16. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, et al. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. Am J Clin Nutr 83: 355–61.
- 17. Sugano K, Yokogawa M, Yuki S, Dohmoto C, Yoshita M, et al. (2012) Effect of cognitive and aerobic training intervention on older adults with mild or no cognitive impairment: a derivative study of the Nakajima Project. Dement Geriatr Cogn Disord Extra 2: 69–80.
- 18. Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, et al. (2013) Differences in the prevalence of dementia and mild cognitive impairment and cognitive functions between early and delayed responders in a community-based study of the elderly. J Alzheimers Dis 37: 691–698.
- 19. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12: 189–198.
- 20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572.
- 21. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43: 2411–2413.
- 22. Morris JC, Storandt M, Miller JP, McKeel DW, Prince JL, et al. (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58: 397–405.
- 23. Lykkesfeldt J, Loft S, Poulsen HE (1995) Determination of ascorbic acid dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection-are they reliable biomarkers of oxidative stress? Anal Biochem 229: 329–335.
- 24. Kamboh MI, Ferrel RE, Kottke B (1998) Genetic studies of human apolipoproteins V: a novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 29: 1535–1543.
- 25. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 3rd ed, revised. Washington DC: Amerian Psychiatric Association.
- 26. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiqlioni L, et al. (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 256: 240–246.
- 27. Peterson J, Dwyer J, Bhagwat S, Haytowitz D, Holden J, et al. (2005) Major flavonoids in dry tea. J Food Compost Anal 18: 487–501.
- 28. Nakagawa K, Miyazawa T (1997) Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol 43: 679–684.
- 29. Bastianetto S, Yao ZX, Papadopoulos V, Quirion R (2006) Neuroprotective effects of green and black teas and their catechin gallate esters against β-amyloid-induced toxicity. Eur J Neurosci 23: 55–64.
- 30. Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, et al. (2012) Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site specific binding. J Biol Chem 2012 287: 14631–14643.
- 31. Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenoic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway. Am J Pathol 175: 2557–2565.
- 32. Barone JJ, Roberts HR (1996) Caffeine consumption. Food Cham Toxicol 34: 119–129.
- 33. Khokhar S, Magnusdottir SGM (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50: 565–570.
- 34. Engelhart MJ, Geerlings MI, Ruitenberg A, Swieten JC, Hofman A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287: 3223–3229.
- 35. Ogawa K, Tsubono Y, Nishino Y, Watanabe Y, Ohkubo T, et al. (2002) Dietary sources of nutrient consumption in a rural Japanese population. J Epidemiol 12: 1–8.
- 36. Science and Technology Agency (2010) Standard tables of food composition in Japan 2010. [on line] Available: www.mext.go.jp/b_menu/shingi/gijyutu/gijyutu3/houkoku/1298713.htm (in Japanese). Accessed 2013 Aug 16.
- 37. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, et al. (2009) L-Theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kB pathways. Free Radic Biol Med 47: 1601–1610.
- 38. Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, et al. (2012) Association of lifetime cognitive engagement and low β-amyloid deposition. Arch Neurol 69: 623–629.
- 39. Bruijin RFG, Schrijvers EMC, Groot KA, Witteman JC, Hofman A, et al. (2013) The association between physical activity and dementia in an elderly population: the Rotterdam study. Eur J Epidemiol 28: 277–283.